Epidemiological Record of Permanent Artificial Cardiac Pacemaker Implant at a Reference Center
Keywords:
Artificial pacemaker, Cardiac arrhythmias, SyncopeAbstract
Objective: To identify the profile of patients who implanted pacemakers and their complications in a tertiary cardiology center in the state of Santa Catarina. Methods: Unicentric, observational and prospective study with 81 patients submitted to pacemaker implantation by the Cardiovascular Surgery Service. Results: Provisional pacemaker was necessary in 42 cases (51.8%) and the average time of temporary pacemaker insertion was 2.2 days. Death occurred in 3 patients (3.7%), however only 1 case (1.2%) was associated with the implant. Conclusion: The clinical characteristics and indications of the implant in the study population were similar to those found in the literature, however the number of complications was high and the length of stay of the provisional pacemaker is beyond that recommended.
Downloads
References
2. Risgaard B, Elming H, Jensen GV, Johansen JB, Toft JC. Waiting for a pacemaker: is it dangerous? EP Europace, 2012;14(7):975– 80. https://doi.org/10.1093/europace/eus016
3. Mosquéra JAP, Pachón Mateos JC, Vargas RNA, Pachón Mateos JC, Piegas LS, Jatene AD, et al. Aspectos epidemiológicos da estimulação cardíaca no Brasil 10 anos do Registro Brasileiro de Marcapassos (RBM). Relampa, 2006;19(1):3–7.
4. Haug B, Kjelsberg K, Lappegård KT. Pacemaker implantation in small hospitals: complication rates comparable to larger centres. EP Europace, 2011;13(11):1580–6. https://doi.org/10.1093/europace/eur162
5. Harding ME. Cardiac implantable electronic device implantation: intraoperative, acute, and remote complications. AACN Adv Crit Care, 2015;26(4):312–9. https://doi.org/10.4037/NCI.0000000000000112
6. Sławiński G, Lewicka E, Kempa M, Budrejko S, Raczak G. Infections of cardiac implantable electronic devices: epidemiology, classification, treatment, and prognosis. Adv Clin Exp Med, 2019;28(2):263–70. https://doi.org/10.17219/acem/80665
7. Pachón MJC, Mosquéra JAP, Pachón MJC, Vargas RNA, Campos Neto CM, Costa ARB. Aspectos epidemiológicos da estimulação cardíaca no Brasil - 12º ano do RBM - Registro Brasileiro de Marcapassos, Desfibriladores e Ressincronizadores Cardíacos. Relampa, 2008;21(1):5–12.
8. Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. EP Europace, 2009;12(1):103–8. https://doi. org/10.1093/europace/eup361
9. Møller M, Arnsbo P, Asklund M, Christensen PD, Gadsbøll N, Svendsen JH. Quality assessment of pacemaker implantations in Denmark. EP Europace, 2002; 4(2):107–12. https:// doi.org/10.1053/eupc.2002.0234
10. Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 2019;74(7):e51–6. https://doi.org/10.1016/j.jacc.2018.10.044
11. Casola Crespo R, Casola Crespo E, Lana R, Lázaro J, Miranda Fragoso ÁE, García C, et al. Registro de implantede marcapasos: trece años de experiencia. Rev AMC, 2016;20(2):135–144.
